Inflammation activated kinase PKR directly targets diseasemodifying residues within α-synuclein and tau for phosphorylation.
2019.06.06 | Health Kommunikation
Date | Fri 14 Jun |
Time | 13:00 — 15:00 |
Location | Lille Anatomisk Auditorium (Building 1231, room 424) |
Friday the 14th of June at 13.00 Lasse Reimer defends his PhD-dissertation entitled: “Inflammation activated kinase PKR directly targets diseasemodifying residues within α-synuclein and tau for phosphorylation.”
The defence is public and takes place in the Lille Anatomisk Auditorium (Building 1231, room 424).
PhD student Lasse Reimer
Mail: lasse.reimer@biomed.au.dk
Tel.: (+45) 4272 8451